Examkin

Soru

Zorluk: ZorStudy Design

A clinical research consortium is planning a trial to evaluate a novel, single-dose adeno-associated virus (AAV) vector gene therapy for a rare, progressive lysosomal storage disorder. Preclinical and early-phase data demonstrate that the therapy permanently integrates into the host genome, resulting in sustained endogenous enzyme production and halting disease progression indefinitely. The disease has a prevalence of 1 in 500,000, making patient recruitment exceedingly difficult. The steering committee is evaluating various trial designs to maximize the utility of the limited patient pool while maintaining rigorous evidence standards. Which of the following study designs is most methodologically inappropriate for evaluating the clinical efficacy of this specific intervention?

  1. Crossover trialCevap
  2. B
    Parallel-group trial
  3. C
    Single-arm trial with historical controls
  4. D
    Stepped-wedge trial
  5. E
    Adaptive design trial

Cevap

Crossover trial
The correct answer identifies the crossover trial as the most inappropriate design. In a crossover trial, each participant receives both the intervention and the control in a randomized sequence, separated by a washout period. The core assumption of this design is that the washout period is sufficient for the participant to return to their baseline state before crossing over to the alternate arm. The vignette explicitly states that the gene therapy permanently integrates into the host genome and halts disease progression indefinitely. Because the treatment effect is permanent, a washout period is biologically impossible. Participants who receive the gene therapy in the first period would still experience its effects during the control period, creating an irreversible carryover effect that invalidates the study results.

Adım Adım Çözüm

1
Analyze the characteristics of the intervention described in the vignette.
The intervention is a single-dose gene therapy that permanently alters the genome and halts disease progression indefinitely.
Understanding the pharmacodynamics and duration of effect is critical for selecting an appropriate study design.
2
Evaluate the methodological requirements of a crossover trial.
Crossover trials require participants to act as their own controls by receiving both treatments in sequence, separated by a washout period that returns them to their baseline state.
To prevent carryover effects from the first period invalidating the results of the second period.
3
Compare the intervention's characteristics to the requirements of the crossover design.
A permanent genomic alteration cannot be 'washed out'. A patient receiving the active therapy in the first period would carry the permanent treatment effect into the control period.
This permanent carryover effect biologically invalidates the fundamental assumption of the crossover design, making it methodologically inappropriate.

Anahtar Kavram

Crossover study designs are strictly contraindicated for interventions that cure a disease or cause permanent, irreversible physiological changes, as the required washout period to return to baseline cannot be achieved.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Study Design

Bu konudan daha fazla soru